PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Ireland brings forward decision on whether to delay July 5 reopening

Sun, 27th Jun 2021 19:49

(Alliance News) - The Irish government is bringing forward a decision on whether to delay the next planned round of Covid-19 relaxations in Ireland, the Taoiseach has said.

Micheal Martin said Cabinet would now deliberate on the scheduled July 5 reopening of indoor hospitality in Ireland early this week.

A decision on the return to indoor dining and drinking had initially been expected later in the week, however, ministers have faced intensifying calls from bar and restaurant owners to urgently provide clarity.

They have made the point that they need to tell their staff whether or not they will be working on July 5.

Martin said there were a number of moving parts to the decision, including the spread of the Delta variant of Covid-19 in Ireland.

He said whether the green light will be given to administering hundreds of thousands of surplus AstraZeneca and Johnson & Johnson vaccines to younger age cohorts in Ireland would also be an "important factor".

In an interview with RTE, Martin said a "steady" approach to the reopening of society had worked to date and he wanted to make sure that there would be "no going back" to forced closures.

"It will be a decision that will be taken early in the week," said Martin.

Martin did not rule out the prospect of the reopening proceeding but with more robust infection control measures in place.

He said "various scenarios" could emerge in how hospitality could operate in the weeks ahead.

The AstraZeneca PLC and Johnson & Johnson's Janssen jabs are currently not given to younger adults in Ireland as a precautionary measure in response to rare incidences of blood clotting linked to the jabs.

Martin said the National Immunisation Advisory Committee was considering whether to alter that advice in the face of the Delta variant's emergence.

He said Niac's advice would influence the National Public Health Emergency Team's deliberations on whether to recommend delaying the July 5 relaxations.

"Given the fact that the Delta variant is here, it's an issue that merits re-examination, it is being re-examined, and Nphet is anxious that that examination would feed into its deliberations," he said.

Martin said the government would also need to examine modelling in respect of the potential impact of the Delta variant.

He said he would also look to how the variant has spread in other countries, such as the UK.

"The calculus is different now, the risk is different now than Christmas time for example," he said.

"We have 2.5 million people vaccinated now, fully vaccinated, with close to four million overall vaccine doses administered – between first and second doses [and] the older age cohorts have been protected.

"So all of that has to feed into the decisions that we take in respect to this.

"And I understand just how difficult and devastating a year it has been for hospitality in particular – we get that, we understand that, and we also understand the need to give early notice."

Martin added: "We're going to engage with public health authorities, cabinet colleagues, the other party leaders and make decisions that are sensible.

"We're very conscious in terms of the impact that the entire pandemic has had on the hospitality sector. I'm always conscious also from the other side of the coin that retail people would have said to me, 'look, when you open this time, we want to stay open' and the same applies to hospitality.

"The worst thing that can happen is you open somebody up and then you start closing again."

International travel for non-essential purposes is set to be permitted across the EU from July 19 as a consequence of the introduction of the bloc's Covid passport.

Martin indicated that Ireland would continue to keep aligned with the rest of Europe on that date.

"We're part of the European framework and we've given a commitment in relation to the 19th, so I think we will continue to operate the European Digital Certificate from the 19th onwards," he said.

Many people within the 60-69 age cohort in Ireland have faced extended waits for their second vaccine jabs.

Martin said action was being taken to address the situation, with the intention to have all second does administered by July 19.

Asked about the government timeline for reducing public spending on Covid-19 supports, Martin said Finance Minister Paschal Donohoe and Public Expenditure Minister Michael McGrath would be making a summer economic statement.

"There will be a clear overall fiscal framework adopted by government in respect of the deficit and over time bring that down," he added.

Martin said the shorter term continuation of current coronavirus policies was important, warning of the potential to "cut off the recovery as it's happening".

He said sectors of the economy would be "weaned off" subsidies "over time".

Meanwhile, the Department of Health confirmed 340 more positive cases of Covid-19 in Ireland on Sunday.

The latest figures also show there are 47 people in hospital with the virus, including 15 in intensive care.

By David Young, PA

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.